esa
esa converts difficult-to-separate composite plastic waste into recycled materials for manufacturers.
UndisclosedUndisclosed
ParticipantMU
Mitsubishi UFJ Capital Co
Activity from announced rounds
Activity in this selectionOct 17, 2026 · Jul 20, 2026
- Rounds participated in
- 3
- Confirmed lead rounds
- 0 2 roles undisclosed
- New companies
- 3 First participation on record · 0 follow-on
- Funding in participating rounds
- $31.6M 2 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
3 in this selectionCORE Biomedicine
Developing the next generation of precision medicines by going beyond genomics.
$21MSeries A
Role not disclosedRege Nephro Co
Developing innovative therapies and medical technologies for patients with kidney diseases who currently have limited treatment options
$10.6MSeries C
Role not disclosed